D008232DisordersC15.604.515C20.683.51511180.988197Lymphoproliferative DisordersFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson0.563920.049352111research area of0.9321920.015909219subject area forPathologyPediatricsPaoloGattusoPaolo Gattuso349288Gattuso, PaoloProfessorLisaBoggioLisa Boggio349587Boggio, LisaAssistant ProfessorParameswaranVenugopalParameswaran Venugopal349597Venugopal, ParameswaranProfessor6Assistant Professor4Professor17099618Goldfarb JM, Larson ML, Venugopal P, Gregory SAClinical advances in hematology & oncology : H&OPosttransplant lymphoproliferative disorder: extranodal marginal zone lymphoma occurring after renal transplantation. Clin Adv Hematol Oncol. 2006 Aug; 4(8):600-4; discussion 604-6.Clin Adv Hematol Oncol2006-08-01T00:00:002006Posttransplant lymphoproliferative disorder: extranodal marginal zone lymphoma occurring after renal transplantation.20085936Evens AM, David KA, Helenowski I, Nelson B, Kaufman D, Kircher SM, Gimelfarb A, Hattersley E, Mauro LA, Jovanovic B, Chadburn A, Stiff P, Winter JN, Mehta J, Van Besien K, Gregory S, Gordon LI, Shammo JM, Smith SE, Smith SMJournal of clinical oncology : official journal of the American Society of Clinical OncologyMulticenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era. J Clin Oncol. 2010 Feb 20; 28(6):1038-46.J Clin Oncol2010-01-19T00:00:002010Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era.26916907Wewel JT, Harbhajanka A, Kasliwal MK, Ahuja SK, Loew JM, Fontes RBJournal of clinical neuroscience : official journal of the Neurosurgical Society of AustralasiaPost-transplant lymphoproliferative disorder of the cervical spine mimicking an epidural abscess. J Clin Neurosci. 2016 Jul; 29:175-8.J Clin Neurosci2016-02-23T00:00:002016Post-transplant lymphoproliferative disorder of the cervical spine mimicking an epidural abscess.Neurological SciencesRush University, Rush Medical College34338127Pearse WB, Petrich AM, Gordon LI, Karmali R, Winter JN, Ma S, Kaplan JB, Behdad A, Klein A, Jovanovic B, Helenowski I, Smith SM, Evens AM, Pro BLeukemia & lymphomaA phase I/II trial of brentuximab vedotin plus rituximab as frontline therapy for patients with immunosuppression-associated CD30+ and/or EBV?+?lymphomas. Leuk Lymphoma. 2021 12; 62(14):3493-3500.Leuk Lymphoma2021-08-02T00:00:002021A phase I/II trial of brentuximab vedotin plus rituximab as frontline therapy for patients with immunosuppression-associated CD30+ and/or EBV?+?lymphomas.true1ProfessorProfessortrue1Assistant ProfessorAssistant ProfessorInternal Medicine, Division of Hematology/Oncology/Cell TherapyNeurological SurgeryIgorKoralnikIgor J. Koralnik349837Koralnik, IgorProfessorRicardoFontesRicardo Fontes349852Fontes, RicardoAssistant Professortrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professortrue1ProfessorProfessor36960939Agrawal P, David KA, Chen Z, Sundaram S, Kim SH, Vaca R, Lin Y, Singer S, Malecek MK, Carter J, Zayac A, Kim MS, Reddy N, Ney D, Habib A, Strouse C, Graber J, Bachanova V, Salman S, Vendiola JA, Hossain N, Tsang M, Major A, Gandhi MK, Keane C, Bond DA, Folstad M, Chang J, Mier-Hicks A, Torka P, Rajakumar P, Venugopal P, Berg S, Glantz M, Goldlust SA, Matnani R, Kumar P, Ollila TA, Cai J, Spurgeon SE, Sieg AG, Cleveland J, Epperla N, Karmali R, Naik S, Smith SM, Rubenstein JL, Kahl BS, Chadburn A, Evens AM, Martin PLeukemia & lymphomaEBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort. Leuk Lymphoma. 2023 05; 64(5):1026-1034.Leuk Lymphoma2023-03-24T00:00:002023EBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort.